1.
Ljuca D, Fatušić Z, Iljazović E, Ahmetović B. Monitoring of chemotherapy successfulness of Platina/Taxol chemotherapy protocol by using determination of serum urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) in patients with ovarian carcinoma FIGO II. Bosn J of Basic Med Sci [Internet]. 2007May20 [cited 2022Dec.8];7(2):113-8. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/3063